GlaxoSmithKline Trading, ZAO,   

Hypoglycemic agent for oral administration
Film-coated tablets, 500 mg + 1 mg, 500 mg + 2 mg.
hypoglycemic agent for oral administration.
Tablets, film-coated, 4 mg and 8 mg.
The double 5α-reductase inhibitor
Capsules 0.5 mg.
Antimicrobial agent
Ointment for external use, 1%.
Adrenomimetics in combination with anticholinergics.

Powder for inhalation dosed, 22 mcg + 55 mcg / dose.

Monoclonal antibodies.
Concentrate for solution for infusion, 20 mg / ml.
Antitumor agent. Antimetabolite

Solution for infusions 5 mg / ml.

Antibiotic

Ointment for external use, 2%.

Antibiotic for topical use

Nasal ointment, 2%.

Hemostatic agent

Lyophilizate for the preparation of a solution for intravenous administration, 250, 500 and 1000 ME complete with a solvent (water for injection).

Cholinesterase inhibitor

Lyophilizate for solution for intravenous administration, 500 ME.

Laxative

Suppositories rectal, 10 mg.

Antiviral agent

Tablets, film-coated, 500 mg.

Local necrotizing agent
Cream for external use, 0,15%.
Antidepressant
Tablets of prolonged action, coated with a coating of 150 mg, 300 mg.
Bronchodilator beta2-adrenomimetic is selective
Aerosol for inhalation dosed, 100 mcg / dose.
Bronchodilator - beta2-adrenomimetic selective
Solution for inhalation, 1 mg / ml.
Endothelin A receptor antagonist selective

Tablets, film-coated, 5 mg and 10 mg.

hemostatic agent

Lyophilizate for the preparation of a solution for intravenous administration, 250 ME + 600 ME, 500 ME + 1200 ME or 1000 ME + 2400 ME.

Glucocorticosteroid for topical application

Ointment for external use, 0.05%.

Non-steroidal anti-inflammatory drug (NSAID).
Suppositories rectal, 50 mg, 100 mg.
keratolytic agent
RA mortar for external use.
An antiviral agent.
Tablets, film-coated, 100 mg.
Antiviral (HIV) agent
Solution for oral administration, 20 mg / ml.
Antibiotic-cephalosporin.
Powder for the preparation of solution for intravenous and intramuscular injection, 250 mg, 750 mg, 1.5 g.
Antibiotic-cephalosporin
Granules for oral suspension, 125 mg / 5 ml.
Antiviral agent
Lyophilizate for the preparation of a solution for infusions 250 mg.
Antiviral for topical use
Eye ointment 3%.
Antiviral agent

Tablets of 200 mg.

Antiemetic, serotonin receptor antagonist
Suppositories rectal, 16 mg.
Antiemetic, serotonin receptor antagonist

Tablets for resorption, 4 mg, 8 mg.

Treatment for acne
Gel for external use, 0.5 mg / g + 20 mg / g.
Anti-migraine means
Tablets coated with a coating, 50 mg and 100 mg.
Anti-migraine means
Spray nasal dosed.
Antiaggregant agent

Solution for intravenous administration 0.75 mg / ml, 2 mg / ml.

MIBP vaccine

Suspension for intramuscular administration complete with lyophilizate for suspension for intramuscular injection, 0.5 ml (1 dose).

Local anesthetic
Gel dental, 3.3 mg + 1.0 mg in 1 g.
Antiviral [HIV] agent
Film-coated tablets, 600 mg + 300 mg.
Hemostatic agent

Lyophilizate for the preparation of a solution for intravenous administration, 250 ME and 500 ME.

Antiviral (HIV) agent
Tablets, film-coated, 300 mg + 150 mg.

Glucocorticosteroid for topical application
Ointment for external use. 0.005%.
Glucocorticosteroid for topical application
Cream for external use. 0.05%.
antiepileptic agent

Tablets, 25 mg, 50 mg and 100 mg.

antiepileptic agent

Tablets are chewable / soluble, 5 mg.

The blocker of "slow" calcium channels

Tablets, film-coated, 2 mg and 4 mg.

Miorelaxant of central action
Tablets, film-coated, 10 mg.
MIBP vaccine
Lyophilizate for the preparation of a solution for subcutaneous administration.
Antibiotic carbapenem
Powder for the preparation of a solution for intravenous administration, 500 mg, 1000 mg.
hemostatic agent

Lyophilizate for solution for intravenous administration, 500 ME and 1000 ME complete with a solvent (water for injection).

ectoparasite remover
Cream for external use 1%.
Antidepressant

Tablets, film-coated, 20 mg.

For 10 tablets in a blister of PVC / aluminum foil or 10 tablets per blister of PVC / PVDH / aluminum foil. For 1, 3 or 10 blisters together with the instructionby medical use is placed in a cardboard box.

MIBP vaccine

Solution for intramuscular injection, 0.5 ml / dose.

MIBP vaccine

Lyophilizate for the preparation of solution for subcutaneous and intramuscular injection, 1 dose (0.5 ml).

MIBP - globulin

Solution for intravenous and intramuscular administration, 750 ME (150 μg) / ml.

An antiparkinsonian agent, a dopamine agonist.
Tablets of prolonged action, film-coated, 2 mg, 4 mg, 8 mg.
Antiviral agent
Powder for inhalation dosed with 5 mg / dose.
An antiviral [HIV] agent.

Solution for oral administration, 50 mg / 5 ml, 200 ml.

An antiviral [HIV] agent.

Capsules 100 mg.

An antiviral [HIV] agent.

Solution for infusions 10 mg / ml.

MIBP vaccine

Suspension for intramuscular injection, 0.5 ml / dose.

Antibiotic, penicillin semisynthetic + beta-lactamase inhibitor
Lyophilizate for the preparation of a solution for intravenous administration, 2 g + 0.25 g and 4 g + 0.50 g.
An antitumour agent, an alkylating compound

Lyophilizate for solution for infusion, 50 mg, 100 mg.

antiviral [HIV] agent

Tablets, film-coated, 50 mg.

Antiviral [HIV] agent
The tablets covered with a film cover, 300 mg + 150 mg + 300 mg.
Antiepileptic agent.
Film-coated tablets, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg.

Glucocorticosteroid for topical application
Spray nasal dosed, 50 mcg / dose.
MIBP vaccine

Suspension for intramuscular and subcutaneous administration.

MIBP vaccine
Lyophilizate for the preparation of solution for intramuscular and subcutaneous injection.
vaccine against human papillomavirus
Suspension for intramuscular injection.
Antiviral [HIV] agent
Film-coated tablets, 300 mg.
Antiviral [HIV] agent

Solution for oral administration, 10 mg / ml.

antiviral [HIV] agent

Tablets, film-coated, 150 mg.